Tag Archives: Houston antibody trials underway in midst of Trump’s ailment

Just as President Trump was receiving a dose of an experimental antibody drug from Regeneron Pharmaceuticals, UTHealth in Houston was signing up its first participant for a trial of a similar antibody treatment from drug maker Eli Lilly. “There’s been a history of using antibody’s to treat infections,” said Dr. Netanya Utay, Associate Professor of Internal Medicine at UTHealth. “The results …

Read More »